Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed or Refractory Acute Myeloid Leukemia”

799 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 799 results

Not applicableNo Longer AvailableNCT03746912
What this trial is testing

Expanded Treatment Protocol for Adults With FLT3-ITD Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) to Receive Quizartinib

Who this might be right for
Acute Myeloid Leukemia With Gene Mutations
Daiichi Sankyo
Early research (Phase 1)Ended earlyNCT03922477
What this trial is testing

A Study Evaluating the Safety and Pharmacokinetics of Atezolizumab Administered in Combination With Hu5F9-G4 to Patients With Relapsed and/or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Hoffmann-La Roche 13
Early research (Phase 1)Study completedNCT00900809
What this trial is testing

QUILT-3.018: Neukoplast™ (NK-92) for the Treatment of Refractory or Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
ImmunityBio, Inc. 7
Early research (Phase 1)UnknownNCT06367673
What this trial is testing

Natural Killer(NK) Cell Therapy Targeting CLL1 or CD33 in Acute Myeloid Leukemia

Who this might be right for
AML, Adult
Zhejiang University 24
Early research (Phase 1)Ended earlyNCT03135028
What this trial is testing

Entospletinib (ENTO) as Monotherapy and in Combination With Chemotherapy in Japanese Adults

Who this might be right for
Hematologic MalignancyAcute Myeloid Leukemia
Gilead Sciences 9
Early research (Phase 1)Study completedNCT03263637
What this trial is testing

Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies

Who this might be right for
Relapsed or Refractory Haematological Malignancies IncludingAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+8 more
AstraZeneca 44
Not applicableEnded earlyNCT05247957
What this trial is testing

NKG2D CAR-NK Cell Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Safety and Efficacy
Hangzhou Cheetah Cell Therapeutics Co., Ltd 9
Testing effectiveness (Phase 2)Study completedNCT01279473
What this trial is testing

Study to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension Study)

Who this might be right for
Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia
Novartis Pharmaceuticals 42
Early research (Phase 1)Active Not RecruitingNCT06618001
What this trial is testing

JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Neoplasms
Janssen Research & Development, LLC 64
Testing effectiveness (Phase 2)Study completedNCT00512083
What this trial is testing

Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia

Who this might be right for
Leukemia, Myeloid
Antisoma Research 70
Early research (Phase 1)Looking for participantsNCT05735184
What this trial is testing

Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Who this might be right for
Acute Myeloid LeukemiaMixed Lineage Leukemia Gene MutationRefractory AML+7 more
Kura Oncology, Inc. 420
Early research (Phase 1)Study completedNCT02096289
What this trial is testing

Safety Study of Thioridazine in Combination With Cytarabine to Treat Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Ontario Clinical Oncology Group (OCOG) 13
Testing effectiveness (Phase 2)Ended earlyNCT05886491
What this trial is testing

GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Leukemia
Takeda 16
Testing effectiveness (Phase 2)Study completedNCT01702155
What this trial is testing

Phase I/II Study of DFP-10917 in Patients With Acute Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic Leukemia
Delta-Fly Pharma, Inc. 69
Very early researchUnknownNCT05574608
What this trial is testing

Allogenic CD123-CAR-NK Cells in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia RefractoryAcute Myeloid Leukemia Recurrent
Affiliated Hospital to Academy of Military Medical Sciences 12
Testing effectiveness (Phase 2)WithdrawnNCT04354025
What this trial is testing

Cytokine-induced Memory-like NK Cells in Combination With Chemotherapy in Pediatric Patents With Refractory or Relapsed AML

Who this might be right for
Refractory Acute Myeloid LeukemiaRelapsed Acute Myeloid Leukemia
Washington University School of Medicine
Testing effectiveness (Phase 2)Ended earlyNCT03071276
What this trial is testing

Selinexor in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
St. Jude Children's Research Hospital 37
Early research (Phase 1)Study completedNCT00004009
What this trial is testing

R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
University of Maryland, Baltimore
Early research (Phase 1)WithdrawnNCT05521087
What this trial is testing

JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias

Who this might be right for
Acute LeukemiasAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+1 more
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Looking for participantsNCT06382168
What this trial is testing

DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Leukemia, Myeloid, Acute
Delta-Fly Pharma, Inc. 39
Next Page